| 0 (0%) | 06-28 18:07 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.49 | 1-year : | 14.24 |
| Resists | First : | 11.55 | Second : | 12.19 |
| Pivot price | 11.06  |
|||
| Supports | First : | 10.5 | Second : | 8.73 |
| MAs | MA(5) : | 11.15  |
MA(20) : | 11.26 |
| MA(100) : | 10.05 |
MA(250) : | 8.67 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 50.8 |
D(3) : | 43 |
| RSI | RSI(14): 53.1 |
|||
| 52-week | High : | 12.19 | Low : | 6.46 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BBVA ] has closed below upper band by 37.3%. Bollinger Bands are 40.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 11.28 - 11.36 | 11.36 - 11.42 |
| Low: | 10.94 - 11.02 | 11.02 - 11.08 |
| Close: | 11.14 - 11.26 | 11.26 - 11.36 |
Tue, 23 Apr 2024
BVA board OKs CWCTC, IU tentative budget - The Mon Valley Independent
Sun, 21 Apr 2024
Change of Job with BVA - Expat Forum
Wed, 17 Apr 2024
Daxor announces two new studies on BVA - TipRanks.com - TipRanks
Tue, 16 Apr 2024
New Studies Prove the Clinical Benefits of Daxor's Blood - GlobeNewswire
Mon, 15 Apr 2024
DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR - GlobeNewswire
Mon, 15 Apr 2024
BVA wins 12-11 shootout with Greensburg Salem - The Mon Valley Independent
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 5,760 (M) |
| Shares Float | 5,640 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 3.1 (%) |
| Shares Short | 2,440 (K) |
| Shares Short P.Month | 2,120 (K) |
| EPS | 1.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.15 |
| Profit Margin | 29.5 % |
| Operating Margin | 50.9 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | 15.9 % |
| Qtrly Rev. Growth | 11.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 4.71 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 33.4 % |
| Operating Cash Flow | -721 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 8.15 |
| PEG Ratio | 0.6 |
| Price to Book value | 1.22 |
| Price to Sales | 2.38 |
| Price to Cash Flow | -89.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|